The effect of SGLT2 inhibitors on hepatic steatosis detected by MRI-PDFF in patients with type 2 Diabetes mellitus and metabolic-associated steatotic liver disease: comment
1 Department of Medicine, Internal Medicine III Unit and Center for the Study and the Integrated Treatment of Obesity, University Hospital of Padova, Via N. Giustiniani 2, 35128, Padua, Italy. angelo.divincenzo@unipd.it.
2 Department of Medicine, Internal Medicine III Unit and Center for the Study and the Integrated Treatment of Obesity, University Hospital of Padova, Via N. Giustiniani 2, 35128, Padua, Italy.